Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells

Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells

US Patent 10806746 · Granted Oct 20, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinat2024
Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinat2024
Method for controlling an SCR catalytic converter2022
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents2022
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents2022
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents2022
Method for controlling an SCR catalytic converter2021
Method for operating an SCR catalytic converter system which has a first SCR cat2020
Determining an ammonia mass flow between two SCR catalytic converters2019
Method for operating an SCR catalyic converter provided for the aftertreatment o2015
Polyol modified aminoglycoside-lipid conjugates2015
Hydrophobically enhanced aminoglycosides2014